Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1127studies shown
Showing 1,001-1,025 of 1,127
CompletedNCT03131505

INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1

This study exists to improve how questionnaires and follow-up reports can help identify, measure, or follow care over time. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Norfolk and Suffolk NHS Foundation Trust
Condition
Schizophrenia
CompletedNCT00908154

Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Biogen
Condition
Bipolarity
TerminatedNCT00483535

Oral Contraceptive Interaction Study for GW273225

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Condition
Bipolarity
CompletedNCT00501865

Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Condition
Bipolarity
CompletedNCT02212041

Electronic Cigarettes in Smokers With Mental Illness

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
CompletedNCT02804867

Spot Depression Study

This study exists to improve how questionnaires and follow-up reports can help identify, measure, or follow care over time. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Cambridge
Condition
Depression
CompletedNCT00459264

Prevention of Mood Disorders by Folic Acid Supplementation

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

BipolarityOtherFrom 14 Years to 24 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Bipolarity
TerminatedNCT01677182

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolarity type I

This study exists to explore whether the medication Ramelteon could improve care and understanding. Researchers are trying to understand whether the medication Ramelteon can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Bulgaria, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, United States
Sponsor
Takeda
Condition
Bipolarity
CompletedNCT01981018

MAPP: Imagery-focused Therapy for Bipolarity

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Medical Research Council Cognition and Brain Sciences Unit
Condition
Bipolarity
CompletedNCT01315028

Bipolar Intervention Study: Cognitive Interpersonal Therapy

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

BipolarityOtherOver 16 Years
Countries
United Kingdom
Sponsor
NHS Greater Glasgow and Clyde
Condition
Bipolarity
RecruitingNCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

This study exists to compare options and see whether the medication ALTO-207 offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

DepressionOtherFrom 18 Years to 75 Years
Countries
United Kingdom, United States
Sponsor
Alto Neuroscience
Condition
Depression
CompletedNCT05202119

Empower: tDCS for Major Depressive Disorder at Home

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

DepressionOtherOver 18 Years
Countries
United Kingdom, United States
Sponsor
Flow Neuroscience AB
Condition
Depression
Not Yet RecruitingNCT07529886

Symptoms of Anxiety and/or Depression and SDM in Older Patients With CLTI

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

AnxietyOtherOver 65 Years
Countries
United Kingdom
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Condition
Anxiety
CompletedNCT05550532

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

This study exists to understand what helps the medication Aticaprant work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to the medication Aticaprant in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Bulgaria, Canada, China, Czech Republic, France, Poland, Slovakia, South Africa, South Korea, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
CompletedNCT07272096

ACTing Minds: An ACT-based Videogame for Mental Health

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

AnxietyOtherOver 18 Years
Countries
United Kingdom
Sponsor
Swansea University
Condition
Anxiety
TerminatedNCT04708834

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

This study exists to better understand the safety of the medication Adjunctive and how manageable it feels in practice. For people living with Mental health, that matters because care needs to work in daily life, not just in theory.

Mental healthOtherFrom 18 Years to 65 Years
Countries
Canada, Italy, Netherlands, Spain, United Kingdom, United States
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
Mental health
CompletedNCT06693609

Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder

This study exists to compare options and see whether the medication EMP-01 offers something meaningfully different. Researchers are trying to understand how people respond to the medication EMP-01 in practice and what may need to be adjusted.

AnxietyOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
atai Therapeutics, Inc.
Condition
Anxiety
Active Not RecruitingNCT06991023

Prebiotic Effects on Anxiety, Cortisol, and Emotional Processing in Mild-to-Moderately Stressed Adults

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

AnxietyOtherFrom 25 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Reading
Condition
Anxiety
Active Not RecruitingNCT06899607

Fibre and Mental Wellbeing Feasibility Trial

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

AnxietyOtherFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Reading
Condition
Anxiety
CompletedNCT04953338

Mental Health Associations With Vitiligo

This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
Momentum Data
Condition
Depression
CompletedNCT05145413

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Bulgaria, India, Japan, Poland, Romania, Serbia, United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia